Bettina Goerner

DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

PhagoMed Biopharma GmbH operates as a biotech company. It specializes in Research, treatment and partnering. The firm also develops alternatives to antibiotics. The company was founded by Alexander Belcredi, Andrej Trampuz, Lorenzo Corsini and Burkhard Wippermann and is headquartered in Vienna, Austria.